Acyl transfer activity of an amidase from Rhodococcus sp. strain R312: Formation of a wide range of hydroxamic acids

Applied and Environmental Microbiology

Volumn 64, Issue 8, 1998, Pages 2844-2852

  Fournand, David ^a   Bigey, Frederic ^a   Arnaud, Alain ^a  

^a MONTPELLIER SUPAGRO   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; AMIDE; HYDROXAMIC ACID;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME BINDING; ENZYME KINETICS; ENZYME PURIFICATION; NONHUMAN; PH; RHODOCOCCUS;

ESCHERICHIA COLI; FELIS CATUS; NEGIBACTERIA; RHODOCOCCUS; RHODOCOCCUS SP.;

EID: 0031879459     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/aem.64.8.2844-2852.1998     Document Type: Article

References (28)

1. Brammar, W. J., and P. H. Clarke. 1964. Induction and repression of Pseudomonas aeruginosa amidase. J. Gen. Microbiol. 37:307-319.
2. Brown, D. A., M. V. Chidambaram, J. J. Clarke, and D. M. McAleese. 1978. Design of iron(III) chelates in oral treatment of anemia: solution properties and absorption of iron(III) acetohydroxamate in anemic rats. Bioinorg. Chem. 9:255-275.
3. Cawston, T. E. 1996. Metalloproteinase inhibitors and the prevention of connective tissue breakdown. Pharmacol. Ther. 70:163-182.
4. Chebrou, H., F. Bigey, A. Arnaud, and P. Galzy. 1996. Study of the amidase signature group. Biochim. Biophys. Acta 1298:285-293.
5. Ciskanik, L. M., J. M. Wilczek, and R. D. Fallon. 1995. Purification and characterization of an enantioselective amidase from Pseudomonas chlororaphis B23. Appl. Environ. Microbiol. 61:998-1003.
6. Fournand, D., A. Arnaud, and P. Galzy. 1998. Study of the acyl transfer activity of a recombinant amidase overproduced in an E. coli strain. Application for short-chain hydroxamic acid and acid hydrazide synthesis. J. Mol. Catal. B 4:77-90.
7. Fournand, D., J. L. Pirat, F. Bigey, A. Arnaud, and P. Galzy. 1997. Spectrophotometric assay of aliphatic monohydroxamic acids and α-, β-, and γ-aminohydroxamic acids in aqueous medium. Anal. Chim. Acta 353:359-366.
8. Gao, W. Y., H. Mitsuya, J. S. Driscoll, and D. G. Johns. 1995. Enhancement by hydroxyurea of the anti-human immunodeficiency virus type 1 potency of 2′-β-fluoro-2′,3′-dideoxyadenosine in peripheral blood mononuclear cells. Biochem. Pharmacol. 50:274-276.
9. Hamer, R. R. L., J. J. Tegeler, E. S. Kurtz, R. C. Allen, S. C. Bailey, M. E. Elliott, L. Hellyer, G. C. Hessley, P. Przekop, B. S. Freed, J. White, and L. L. Martin. 1996. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical anti-inflammatory activity. J. Med. Chem. 39:246-252.
10. Hashimoto, Y., M. Nishiyama, O. Ikehata, S. Horinouchi, and T. Beppu. 1991. Cloning and characterization of an amidase gene from Rhodococcus species N-774 and its expression in Escherichia coli. Biochim. Biophys. Acta 1088:225-233.
11. Heitner, H. I., and R. G. Ryles. November 1992. European patent 0 514 648 B1.
12. Hirrlinger, B., A. Stolz, and H.-J. Knackmuss. 1996. Purification and properties of an amidase from Rhodococcus erythropolis MP50 which enantioselectively hydrolyzes 2-arylpropionamides. J. Bacteriol. 178:3501-3507.
13. Holmes, L. B. 1996. Hydroxamic acid: a potential human teratogen that could be recommended to treat ureaplasma. Teratology 53:227-229.
14. Kobayashi, M., H. Komeda, T. Nagasawa, M. Nishiyama, S. Horinouchi, T. Beppu, H. Yamada, and S. Shimizu. 1993. Amidase coupled with low-molecular-mass nitrile hydratase from Rhodococcus rhodochrous J1. Eur. J. Biochem. 217:327-336.
15. Kobayashi, M., Y. Fujiwara, M. Goda, H. Komeda, and S. Shimizu. 1997. Identification of active sites in amidase: evolutionary relationship between amide bond- and peptide bond-cleaving enzymes. Proc. Natl. Acad. Sci. USA 94:11986-11991.
16. Koide, Y., M. Uchino, and K. Yamada. 1987. Studies of collectors. IX. The flotation of a trace amount of uranium by using 2-(alkylamino)propionohydroxamic acid and cotelomer-type surfactants bearing hydroxyaminocarbonyl and pyridyl groups. Bull. Chem. Soc. Jpn. 60:3477-3483.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
18. Lewellyn, M. E. May 1996. World patent WO 96/14271.
19. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
20. Mayaux, J.-F., E. Cerbelaud, F. Soubrier, D. Faucher, and D. Pétré. 1990. Purification, cloning, and primary structure of an enantiomer-selective amidase from Brevibacterium sp. strain R312: structural evidence for genetic coupling with nitrile hydratase. J. Bacteriol. 172:6764-6773.
21. Mayaux, J.-F., E. Cerbelaud, F. Soubrier, P. Yeh, F. Blanche, and D. Pétré. 1991. Purification, cloning, and primary structure of a new enantiomerselective amidase from Rhodococcus strain: structural evidence for a conserved genetic coupling with nitrile hydratase. J. Bacteriol. 173:6694-6704.
22. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
23. Segel, I. H. 1975. Enzyme kinetics, p. 602-625. John Wiley & Sons, New York, N.Y.
24. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 polymerase to direct expression of cloned genes. Methods Enzymol. 185:60-89.
25. Studier, F. W., and B. A. Moffatt. 1986. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J. Mol. Biol. 189:113-130.
26. Thiéry, A., M. Maestracci, A. Arnaud, P. Galzy, and M. Nicolas. 1986. Purification and properties of an acylamide amidohydrolase (E.C. 3.5.1.4) with a wide activity spectrum from Brevibacterium sp. R312. J. Basic Microbiol. 26:299-311.
27. Trott, S. Personal communication.
28. Tsafack, A., J. Golenser, J. Libman, A. Shanzer, and Z. I. Cabantchik. 1995. Mode of action of iron(III) dictators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum. Mol. Pharmacol. 47:403-409.